NCT02817516View on ClinicalTrials.gov

A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of TAK-828 Escalating Multiple-Doses in Healthy Participants

PHASE1TerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

August 22, 2016

Study Completion Date

August 22, 2016

Conditions
Healthy Volunteers
Interventions
DRUG

TAK-828

TAK-828 solution.

DRUG

Placebo

TAK-828 placebo-matching solution.

Trial Locations (1)

Unknown

Austin

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY